You are here: Industry Insights > Allergan

News List

Yehia Hashad Will Join Bausch + Lomb as EVP of R&D and CMO FirstWordPharma
January 21, 2022
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") has announced that Dr. Yehia Hashad will join Bausch + Lomb Corporation ("Bausch + Lomb") as executive vice president...
PMEA 2021: A Celebration of Excellence in Patient Engagement PharmaTimes
December 02, 2021
The 21st annual PMEAs returned to host attendees gathering in-person for a live awards show to recognise the achievement in pharmaceutical marketing excellence.
New Data Presented on the Safety and Efficacy of Investigational AGN-190584 as a Potential Novel Treatment for Presbyopia, a Common and Progressive Eye Condition drugs
July 30, 2021
Allergan today announced new data, including the full results from the Phase 3 GEMINI 1 clinical study, evaluating the efficacy, safety and tolerability of investigational AGN-190584 ophthalmic solution for the treatment of presbyopia.
Allergan Announces Positive Phase 3 Topline Results for Presbyopia Trial americanpharmaceuticalreview
November 05, 2020
Allergan, an AbbVie company, announced the Phase 3 GEMINI 1 and 2 clinical trials evaluating the efficacy, safety and tolerability of investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of symptoms associated with ...
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData expresspharma
September 24, 2020
Johnson & Johnson maintained its top position with MCap growth of 7.2 per cent on a QoQ basis.
AstraZeneca Recovers Global Rights to brazikumab from Allergan americanpharmaceuticalreview
May 14, 2020
AstraZeneca has completed a previously communicated agreement to recover the global rights to brazikumab (formerly MEDI2070), a monoclonal antibody targeting IL23, from Allergan.
AbbVie completes acquisition of Allergan expresspharma
May 14, 2020
The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in immunology.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.
AstraZeneca regains global rights to brazikumab from Allergan pharmaceutical-technology
May 12, 2020
AstraZeneca has regained global rights to brazikumab (previously MEDI2070) from Allergan, following the termination of a prior licensing deal between the companies.
FTC Clears AbbVie’s Acquisition of Allergan contractpharma
May 07, 2020
Only one Allergan director will join the AbbVie board after close.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page